Schinazi Raymond F 4
4 · Cocrystal Pharma, Inc. · Filed May 6, 2021
Insider Transaction Report
Form 4
Schinazi Raymond F
Director10% Owner
Transactions
- Sale
Common Stock
2021-05-04$2.95/sh−575,000$1,696,250→ 7,674,960 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $2.60 to $3.25, inclusive. The Reporting Person undertakes to provide to Cocrystal Pharma, Inc., any security holder of Cocrystal Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in footnote (1) to this Form 4.